Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.

RCMI Coordinating Center (RCMI CC)

Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies.

Beck AK, Pass HI, Carbone M, Yang H. Ranpirnase as a potential antitumor ribonuclease treatment for mesothelioma and other malignancies. Future Oncol. 2008 Jun; 4(3):341-9.

View in: PubMed

subject areas

Animals
Antineoplastic Agents
Clinical Trials as Topic
Humans
Mesothelioma
Neoplasms
Rana pipiens
Ribonucleases

authors with profiles

Michele Carbone, MD, PhD.

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support